Fundz

Variant Bio, Inc. reported raising $6.1 Million in an initial SEC Form D filing, from an offering of $6.7 Million

PRIVATEAug 05, 2020$6.1M of $6.7M raised

Amount Raised

$6.1 Million

$6.1 Million sold, per SEC Form D (first sale Aug 5, 2020)

Round Type

Venture

SeattleBiotechnology

Quick answer

Variant Bio raised $6.1 Million in a funding round, dated August 5, 2020. Variant Bio is based in Seattle, Washington, United States.

How much did Variant Bio raise?
Variant Bio raised $6.1 Million in a funding round on August 5, 2020.
What does Variant Bio do?
Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.
Where is Variant Bio based and how big is it?
Variant Bio is based in Seattle, Washington, United States. Fundz records about 45 employees.
Who are the decision-makers at Variant Bio?
Fundz holds 1 contact at Variant Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Variant Bio that raised within 45 days of this round, from Fundz verified event records.

  • Silicon Valley Innovations, Inc. raised $2.6M (Seed) on September 18, 2020.
  • Lassogen, Inc. raised $5.1M on September 18, 2020.
  • Finch Therapeutics Group, Inc. raised $88M on September 17, 2020.
  • LAVA Therapeutics raised $83M (Series C) on September 17, 2020.
  • AgroSpheres raised $485K (Seed) on September 17, 2020.
  • BioNTech raised $250M on September 17, 2020.

Who to call at Variant Bio, and when

A new round usually means Variant Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Variant Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Variant Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Variant Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Variant Bio

Location

188 E Blaine St, Suite 126

Seattle, Washington, United States

About

Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Variant Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts16 people are listed at Variant Bio. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Variant Bio's next move

See what Strategic adds

Variant Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.